Lv1
50 积分 2023-09-27 加入
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trials
1个月前
已完结
[Prevalence of allergic rhinitis in Chinese children from 2001 to 2021: Meta analysis]
4个月前
已完结
Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion–Mutated Breast Cancer
9个月前
已关闭
皖公网安备34019202002308
